Severe enterovirus type 71 nervous system infections in children in the Shanghai region of China: Clinical manifestations and implications for prevention and care

Pediatric Infectious Disease Journal

Volumn 33, Issue 5, 2014, Pages 482-487

  Zhang, Qingli ^a   MacDonald, Noni E ^b   Smith, Jennifer C ^b   Cai, Kang ^a   Yu, Huiju ^a   Li, Huajun ^a   Lei, Chuene ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

children; China; clinical findings; Enterovirus 71; intravenous gamma globulin intervention

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN;

ARTICLE; ASEPTIC MENINGITIS; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CHILDHOOD DISEASE; CHINA; CLINICAL FEATURE; COMA; CONTROLLED STUDY; DISEASE SEVERITY; ENCEPHALITIS; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; EPIDEMIC; FEMALE; HAND FOOT AND MOUTH DISEASE; HERPANGINA; HUMAN; INFANT; INTENSIVE CARE UNIT; LUNG EDEMA; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENINGOENCEPHALITIS; MYOCLONUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; SURVIVAL; ADOLESCENT; ENCEPHALITIS, VIRAL; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; PATHOLOGY; TERTIARY CARE CENTER; VIROLOGY;

ADOLESCENT; CHILD; CHINA; DISEASE OUTBREAKS; ENCEPHALITIS, VIRAL; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84899095565     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000194     Document Type: Article

References (28)

1. Wilson MR. Emerging viral infections. Curr Opin Neurol. 2013;26: 301-306.
2. Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778-790.
3. Joshi R, Kalantri SP, Reingold A, et al. Changing landscape of acute encephalitis syndrome in India: a systematic review. Natl Med J India. 2012;25:212-220.
4. Choi CS, Choi YJ, Choi UY, et al. Clinical manifestations of CNS infections caused by enterovirus type 71. Korean J Pediatr. 2011;54:11-16.
5. Podin Y, Gias EL, Ong F, et al. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health. 2006;6:180.
6. Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999;341:929-935.
7. Tu PV, Thao NT, Perera D, et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 2007;13:1733-1741.
8. Zhang Y, Tan XJ, Wang HY, et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol. 2009;44:262-267.
9. Honkanen H, Oikarinen S, Pakkanen O, et al. Human enterovirus 71 strains in the background population and in hospital patients in Finland. J Clin Virol. 2013;56:348-353.
10. World Health Organization. Severe complications of hand, foot and mouth disease (HFMD) caused by EV-71 in Cambodia-conclusion of the joint investigation. 2012. Available at: http://www.who.int/csr/don/2012-07-13/en/. Accessed April 29, 2013.
11. Zou XN, Zhang XZ, Wang B, et al. Etiologic and epidemiologic analysis of hand, foot, and mouth disease in Guangzhou city: a review of 4,753 cases. Braz J Infect Dis. 2012;16:457-465.
12. Yan XF, Gao S, Xia JF, et al. Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16. Scand J Infect Dis. 2012;44:297-305.
13. Hu HY, Qiao R, Sheng Q, et al. [Detection the pathogens and analysis the clinical characteristics in children with hand, foot and mouth disease in Shanghai during 2009-2011]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2012;26:341-343.
14. Shanghai Municipal Health Bureau. Number 53 document. July 1,2009.
15. Shanghai City Board of Education. Number 41 document. July 7, 2009.
16. Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097-1105.
17. Lee MK, Chan PK, Ho II, et al. Enterovirus infection among patients admitted to hospital in Hong Kong in 2010: epidemiology, clinical characteristics, and importance of molecular diagnosis. J Med Virol. 2013;85:1811-1817.
18. Chan LG, Parashar UD, Lye MS, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis. 2000;31:678-683.
19. Cho HK, Lee NY, Lee H, et al. Enterovirus 71-associated hand, foot and mouth diseases with neurologic symptoms, a university hospital experience in Korea, 2009. Korean J Pediatr. 2010;53:639-643.
20. Liu MY, Liu W, Luo J, et al. Characterization of an outbreak of hand, foot, and mouth disease in Nanchang, China in 2010. PLoS One. 2011;6:e25287.
21. Gau SS, Chang LY, Huang LM, et al. Attention-deficit/hyperactivity- related symptoms among children with enterovirus 71 infection of the central nervous system. Pediatrics. 2008;122:e452-e458.
22. Ooi MH, Wong SC, Podin Y, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 2007;44:646-656.
23. Wang SM, Liu CC, Tseng HW, et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 1999;29:184-190.
24. Han JF, Cao RY, Deng YQ, et al. Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo. Virol J. 2011;8:106.
25. Cao RY, Dong DY, Liu RJ, et al. Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection. PLoS One. 2013;8:e64024.
26. Ruan F, Yang T, Ma H, et al. Risk factors for hand, foot, and mouth disease and herpangina and the preventive effect of hand-washing. Pediatrics. 2011;127:e898-e904.
27. Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024-2032.
28. Tan X, Huang X, Zhu S, et al. The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One. 2011;6:e25662.